6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0206
ID: 36C77025Q0206Type: Solicitation
AwardedJun 10, 2025
$827.8K$827,751
AwardeePharmacy Buying Association, Inc. KANSAS CITY 64120
Award #:36C77025P0180
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/289630d9e9f34e409474ea0db6c3dbb4/view
Timeline
    Description

    The Department of Veterans Affairs is seeking vendors to supply various dosages of Ibuprofen as part of a procurement for pharmaceuticals, specifically under solicitation number 36C77025Q0206. The requirement includes multiple quantities of Ibuprofen 400mg, 600mg, and 800mg tablets, which will be delivered to several locations within the Veterans Affairs network. This procurement is crucial for ensuring a consistent supply of essential medications for veterans, adhering to federal regulations and standards, including compliance with the Drug Supply Chain Security Act (DSCSA). Interested vendors must submit their quotes by April 24, 2025, at 09:00 AM (CST), and can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134 for further details.

    Point(s) of Contact
    Larry M ZaritzContract Specialist
    larry.zaritz@va.gov
    Files
    Title
    Posted
    36C77025Q0206_1.docx
    The document outlines a Request for Proposal (RFP) by the Department of Veterans Affairs (VA) for pharmaceutical supplies, specifically for various types of ibuprofen tablets packaged in bulk. It details requirements for suppliers, including adherence to the Drug Supply Chain Security Act, provision of National Drug Codes (NDCs), and strict delivery schedules to various VA facilities. Suppliers must provide pricing details, regulatory compliance documentation, and confirmation of product availability prior to order processing. Additional stipulations include the requirement for barcode labeling per industry standards, clear terms on acceptance of products, invoicing procedures, payment terms, and conditions under which the government may terminate the contract. The focus is on ensuring safe, compliant pharmaceutical supply while engaging with diverse business types, emphasizing support for small businesses and specific eligibility categories. This RFP serves the broader context of federal procurement, targeting an efficient and regulated method of sourcing essential health products for veterans.
    36C77025Q0206.docx
    The document is a presolicitation notice issued by the Department of Veterans Affairs for the procurement of miscellaneous pharmaceuticals, specifically Ibuprofen in various dosages and quantities, for delivery to multiple locations within the Veterans Affairs network. The solicitation number is 36C77025Q0206, with response submissions due by April 24, 2025, at 09:00 AM (CST). This procurement is classified under medical equipment and pharmaceutical preparation manufacturing (NAICS code 325412). Vendors are required to provide a price schedule in Excel format, their state wholesale distributor license, and to comply with the Drug Supply Chain Security Act (DSCSA). The estimated award date is April 29, 2025, and the delivery timeframe is 10 days after receipt of order. Importantly, the solicitation is set aside as unrestricted, inviting participation from all interested sources. This notice emphasizes the need for U.S.-made products and necessitates that vendors monitor updates regarding solicitation changes on the Contract Opportunities website. Overall, this solicitation serves as a formal invitation for vendors to submit bids for a consistent supply of pharmaceuticals needed by Veterans Affairs facilities, ensuring compliance with federal regulations and standards.
    52.225-6 TRADE AGREEMENTS CERTIFICATE.docx
    The document outlines the Trade Agreements Certificate as part of federal procurement guidelines. It states that offerors must certify that their products are either U.S.-made or from designated countries, as defined in the associated Trade Agreements clause. Any products that are not compliant must be listed in a designated section. The evaluation of these offers will adhere to the Federal Acquisition Regulation's Part 25 policies. Specifically for goods under the WTO General Procurement Agreement, U.S.-made or designated country products are considered without the Buy American statute’s restrictions, facilitating broader procurement options. However, only compliant products may be awarded unless the Contracting Officer concludes there are insufficient offers meeting the criteria. This provision ensures adherence to trade agreements while fostering fair competition among suppliers in government solicitations.
    S02_Solicitation_Attachment_Pricing SpreadSheet_RFQ_36C77025Q0206.xlsx
    The file outlines a Request for Quote (RFQ) for the supply of Ibuprofen in various dosages and quantities, issued by the Department of Veterans Affairs (VA). The RFQ number is 36C77025Q0206, with an estimated issue date of April 17, 2025, and a closing date set for April 24, 2025, at 9:00 AM CST. Bids should be emailed to Michael McAlhaney at the VA. The required items include Ibuprofen 400mg, 600mg, and 800mg tablets, each in multiple batch sizes. Vendors must comply with the Drug Supply Chain Security Act (DSCSA) and provide proof of state wholesale distributor licensure to be deemed acceptable. Documentation and quotes must include specific forms, such as SF1449, state licenses, and compliance certificates. Key contact information for various VA locations is provided, highlighting the logistical framework for supply and communication. The purpose of this RFQ is to secure pharmaceutical supplies for the VA, emphasizing adherence to regulatory standards and streamlined communication with potential suppliers. This initiative reflects the VA's commitment to maintaining an efficient drug supply chain to support veterans' healthcare needs.
    Similar Opportunities
    6505--LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB (VA-26-00008212)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking small business vendors to supply LEVOFLOXICIN 750MG / DEXTROSE 5% 150ML, IVPB, as part of solicitation number 36C77026Q0005. This procurement involves delivering a total of 1,460 boxes of the pharmaceutical product to the VA CMOP facility in Hines, Illinois, with a base period and four option years, each requiring delivery by January 5th of the respective year. The goods are critical for patient care within the VA healthcare system, emphasizing the importance of timely and compliant delivery. Interested vendors must submit their proposals, including a signed SF 1449, pricing schedule, and other required documentation, by December 16, 2025, at 3 PM Central Time, and can direct inquiries to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov.
    6505--Carbidopa Levodopa Immediate Release (IR) Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets, aimed at ensuring a reliable supply for various federal health care entities, including the VA, Department of Defense (DoD), and Bureau of Prisons (BOP). The procurement will involve awarding a single contract for an initial one-year period, with the possibility of four additional one-year option periods, to maintain an uninterrupted supply of these essential medications. The estimated annual requirements detail various dosages and package sizes, with total usage ranging from 2,008 to 118,764 bottles depending on the item. The solicitation is expected to be released around December 18, 2025, with a closing date of January 8, 2026; interested parties should direct inquiries to Ray Roldan at Raymond.Roldan@va.gov or call 708-786-4930.
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--Ustekinumab Pens/Syringes or Biosimilar
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ustekinumab Pens/Syringes or Biosimilars, aimed at supplying various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract will be awarded for an initial period of one year, with the possibility of four additional one-year option periods, ensuring a consistent supply of these critical pharmaceutical products through the VA and DoD Pharmaceutical Prime Vendor Programs. Offerors must provide drugs with unique National Drug Code (NDC) numbers and ensure that any biosimilar products meet FDA licensing requirements, as outlined in the FDA Purple Book. The solicitation is expected to be released around January 12, 2026, with a tentative closing date of January 27, 2026; interested parties should direct inquiries to Chris Carthron at Christopher.Carthron@va.gov or (708) 786-4980.
    6505--Zonisamide Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers for a Firm Fixed Price, Indefinite-Delivery Requirements contract for Zonisamide Capsules in 25mg, 50mg, and 100mg dosages. Offerors are required to provide pricing for a base year and four option years, submit a 0.5% Cost Recovery Fee, and comply with stringent packaging and barcoding standards, including adherence to the Drug Supply Chain Security Act (DSCSA) and National Drug Code (NDC) requirements. These pharmaceutical products are crucial for the healthcare services provided to veterans and military personnel through the VA and DoD Pharmaceutical Prime Vendor Programs. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details, and ensure they meet all compliance and registration requirements, including current SAM registration.
    6505--Biologics by McKesson Specialty Pharmacy (Lenalidomide) (VA-26-00016920)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified suppliers to provide Lenalidomide, a pharmaceutical product, for the Oscar G. Johnson VA Medical Center located in Iron Mountain, MI. This procurement will be conducted through a Brand Name or Equal Request for Quotation (RFQ) under firm-fixed price terms, following FAR Part 13 Simplified Acquisition Procedures. Lenalidomide is crucial for treating certain conditions, making this procurement significant for patient care within the VA system. Interested offerors must submit an itemized quote along with sufficient technical documentation via email to arneil.genus@va.gov by 3 p.m. Central on December 1, 2025, as telephone inquiries will not be accepted.
    NATIONAL OPERATIONAL/MAILING SUPPLIES
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for operational and mailing supplies through solicitation number 36C77025R0004, aimed at supporting its seven Consolidated Mail Outpatient Pharmacy (CMOP) locations. This procurement involves establishing multiple National Single Award Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for essential items such as corrugated boxes, bubble mailers, sealing tape, and child-resistant medical pouches, ensuring compliance with stringent specifications for patient safety and product integrity. The awarded contracts will facilitate timely deliveries of these supplies, which are critical for the efficient processing and shipment of prescriptions to veterans. Interested vendors must submit their proposals, including product samples and pricing schedules in Excel format, by the extended deadline of January 15, 2026, at 5:00 PM CDT. For further inquiries, contact Kelly L Mann at kelly.mann@va.gov or Kelley Cunningham at kelley.cunningham@va.gov.
    6515--550-26-1-985-0034 InstyMed Dispenser System (VA-26-00024776)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) intends to negotiate a limited source contract with InstyMeds for the procurement of an InstyMed Dispenser System, specifically for use at the Danville VA Medical Center and various Community-Based Outpatient Clinics (CBOCs). The VA requires four InstyMed Medication Dispensing Systems to enhance the efficiency of medication delivery from provider orders to patients, ensuring timely access to medications. This automated system is critical for pharmacy operations, offering features such as location-specific formulary management, real-time inventory tracking, and integration capabilities with existing systems like Vista, with potential for future compatibility with Cerner. For further inquiries, interested parties can contact Vernise L. Newton at vernise.newton@va.gov or by phone at 414-844-4800 x43248.
    Metaxalone Tablets
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is soliciting proposals for the supply of Metaxalone 800 MG tablets, available in 100-count and 500-count bottles. This procurement aims to establish a requirements contract with estimated annual quantities for a base year and four option years, emphasizing the need for compliance with various federal acquisition regulations and ethical standards. Metaxalone is a critical medication used for muscle relaxation, making this contract vital for supporting military health services. Interested vendors must submit their proposals electronically via the Defense Logistics Agency Internet Bid Board System (DIBBS) between November 7 and December 7, 2025, by 3:00 PM EST. For further inquiries, contact Jeremy Brown at jeremy.brown@dla.mil or Jason Wray at Jason.wray@dla.mil.
    Pharmaceutical Repackaging Services for National CMOP (770)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for pharmaceutical repackaging services for the National Consolidated Mail Outpatient Pharmacy (CMOP) program. The contract, identified as 36C77026R0004, is a firm-fixed-price, indefinite-delivery agreement intended to support the repackaging of government-purchased oral solid pharmaceuticals into various bottle sizes for distribution to over 7 million veterans. The contract spans a five-year ordering period from February 1, 2026, to January 31, 2031, with a potential six-month extension, and has a minimum value of $20 million and a maximum value of $125 million. Interested contractors should contact Renee Kreutzer at renee.kreutzer@va.gov for further details and must submit their proposals by the specified deadlines, ensuring compliance with all relevant regulations and standards.